Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-21 4:21 pm Sale | 13D | Icosavax Inc. ICVX | Qiming U.S. Healthcare GP II LLC | 0 0.000% | -3,523,561 (Position Closed) | View |
2024-02-21 4:17 pm Sale | 13D | Icosavax Inc. ICVX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,985,843 (Position Closed) | View |
2024-02-14 4:58 pm Sale | 13G | Icosavax Inc. ICVX | CITADEL ADVISORS LLC | 283,079 0.600% | -1,906,390 (-87.07%) | View |
2024-02-14 4:01 pm Purchase | 13G | Icosavax Inc. ICVX | Pentwater Capital Management LP | 3,000,000 5.900% | 3,000,000 (New Position) | View |
2024-02-14 10:04 am Sale | 13G | Icosavax Inc. ICVX | T. Rowe Price Investment Management Inc. | 3,926,407 7.800% | -537,118 (-12.03%) | View |
2024-02-13 10:37 am Unchanged | 13G | Icosavax Inc. ICVX | PLATINUM INVESTMENT MANAGEMENT LTD | 0 0.000% | 0 (Unchanged) | View |
2024-02-07 5:09 pm Sale | 13G | Icosavax Inc. ICVX | BlackRock Inc. BLK | 2,467,810 4.900% | -113,720 (-4.41%) | View |
2024-02-02 3:57 pm Purchase | 13G | Icosavax Inc. ICVX | BlackRock Inc. BLK | 2,581,530 5.200% | 2,581,530 (New Position) | View |
2024-01-10 08:53 am Sale | 13G | Icosavax Inc. ICVX | FMR LLC | 2,240,524 4.506% | -2,644,847 (-54.14%) | View |
2023-11-24 3:20 pm Sale | 13D | Icosavax Inc. ICVX | ADAMS STREET PARTNERS LLC | 2,095,087 4.200% | -122,531 (-5.53%) | View |
2023-07-25 4:18 pm Purchase | 13G | Icosavax Inc. ICVX | TCG Crossover GP I LLC | 3,703,704 7.500% | 3,703,704 (New Position) | View |
2023-06-12 6:45 pm Sale | 13D | Icosavax Inc. ICVX | ADAMS STREET PARTNERS LLC | 2,217,618 5.400% | -398,951 (-15.25%) | View |
2023-06-05 4:25 pm Purchase | 13G | Icosavax Inc. ICVX | CITADEL ADVISORS LLC | 2,189,469 5.300% | 2,189,469 (New Position) | View |
2023-05-30 5:00 pm Purchase | 13D | Icosavax Inc. ICVX | RA CAPITAL MANAGEMENT L.P. | 5,985,843 12.500% | 206,496 (+3.57%) | View |
2023-02-14 06:10 am Sale | 13G | Icosavax Inc. ICVX | NanoDimension III L.P. | 1,261,658 3.200% | -1,488,336 (-54.12%) | View |
2023-02-09 10:31 am Unchanged | 13G | Icosavax Inc. ICVX | PLATINUM INVESTMENT MANAGEMENT LTD | 0 0.000% | 0 (Unchanged) | View |
2023-01-10 4:02 pm Purchase | 13G | Icosavax Inc. ICVX | T. Rowe Price Investment Management Inc. | 4,463,525 11.200% | 4,463,525 (New Position) | View |
2023-01-10 12:48 pm Purchase | 13G | Icosavax Inc. ICVX | FMR LLC | 4,885,371 12.243% | 4,885,371 (New Position) | View |
2022-12-21 5:16 pm Sale | 13D | Icosavax Inc. ICVX | ADAMS STREET PARTNERS LLC | 2,616,569 6.600% | -775,823 (-22.87%) | View |
2022-02-28 4:02 pm Purchase | 13D | Icosavax Inc. ICVX | Qiming U.S. Healthcare GP II LLC | 3,523,561 9.000% | 3,523,561 (New Position) | View |